These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

816 related items for PubMed ID: 7901753

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Use of subunit-specific antisense oligodeoxynucleotides to define developmental changes in the properties of N-methyl-D-aspartate receptors.
    Zhong J, Gribkoff VK, Molinoff PB.
    Mol Pharmacol; 1996 Sep; 50(3):631-8. PubMed ID: 8794904
    [Abstract] [Full Text] [Related]

  • 25. Factors that enhance ethanol inhibition of N-methyl-D-aspartate receptors in cerebellar granule cells.
    Popp RL, Lickteig RL, Lovinger DM.
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1564-74. PubMed ID: 10336554
    [Abstract] [Full Text] [Related]

  • 26. Stimulatory and inhibitory properties of aminoglycoside antibiotics at N-methyl-D-aspartate receptors.
    Masuko T, Kuno T, Kashiwagi K, Kusama T, Williams K, Igarashi K.
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1026-33. PubMed ID: 10454474
    [Abstract] [Full Text] [Related]

  • 27. Cyclophane and acyclic cyclophane: novel channel blockers of N-methyl-D-aspartate receptor.
    Masuko T, Nagaoka H, Miyake M, Metori K, Kizawa Y, Kashiwagi K, Igarashi K, Kusama T.
    Neurochem Int; 2007 Jan; 50(2):443-9. PubMed ID: 17113196
    [Abstract] [Full Text] [Related]

  • 28. In vitro characterization of novel NR2B selective NMDA receptor antagonists.
    Kiss L, Cheng G, Bednar B, Bednar RA, Bennett PB, Kane SA, McIntyre CJ, McCauley JA, Koblan KS.
    Neurochem Int; 2005 May; 46(6):453-64. PubMed ID: 15769547
    [Abstract] [Full Text] [Related]

  • 29. Structure-activity relationships for a series of bis(phenylalkyl)amines: potent subtype-selective inhibitors of N-methyl-D-aspartate receptors.
    Tamiz AP, Whittemore ER, Zhou ZL, Huang JC, Drewe JA, Chen JC, Cai SX, Weber E, Woodward RM, Keana JF.
    J Med Chem; 1998 Aug 27; 41(18):3499-506. PubMed ID: 9719603
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Ifenprodil and SL 82.0715 as cerebral antiischemic agents. III. Evidence for antagonistic effects at the polyamine modulatory site within the N-methyl-D-aspartate receptor complex.
    Carter CJ, Lloyd KG, Zivkovic B, Scatton B.
    J Pharmacol Exp Ther; 1990 May 27; 253(2):475-82. PubMed ID: 1971016
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Differential effects of linear and cyclic polyamines on NMDA receptor activities.
    Masuko T, Miyake M, Kusama-Eguchi K, Koike T, Kimura E, Kizawa Y, Kashiwagi K, Igarashi K, Kusama T.
    Neurochem Int; 2008 Jul 27; 53(1-2):38-44. PubMed ID: 18556092
    [Abstract] [Full Text] [Related]

  • 35. Monoamines directly inhibit N-methyl-D-aspartate receptors expressed in Xenopus oocytes in a voltage-dependent manner.
    Masuko T, Suzuki I, Kizawa Y, Kusama-Eguchi K, Watanabe K, Kashiwagi K, Igarashi K, Kusama T.
    Neurosci Lett; 2004 Nov 16; 371(1):30-3. PubMed ID: 15500961
    [Abstract] [Full Text] [Related]

  • 36. Single channel analysis of a novel NMDA channel from Xenopus oocytes expressing recombinant NR1a, NR2A and NR2D subunits.
    Cheffings CM, Colquhoun D.
    J Physiol; 2000 Aug 01; 526 Pt 3():481-91. PubMed ID: 10922001
    [Abstract] [Full Text] [Related]

  • 37. Pharmacological characterization of Ro 63-1908 (1-[2-(4-hydroxy-phenoxy)-ethyl]-4-(4-methyl-benzyl)-piperidin-4-ol), a novel subtype-selective N-methyl-D-aspartate antagonist.
    Gill R, Alanine A, Bourson A, Buttelmann B, Fischer G, Heitz MP, Kew JN, Levet-Trafit B, Lorez HP, Malherbe P, Miss MT, Mutel V, Pinard E, Roever S, Schmitt M, Trube G, Wybrecht R, Wyler R, Kemp JA.
    J Pharmacol Exp Ther; 2002 Sep 01; 302(3):940-8. PubMed ID: 12183650
    [Abstract] [Full Text] [Related]

  • 38. Functional in vitro characterization of CR 3394: a novel voltage dependent N-methyl-D-aspartate (NMDA) receptor antagonist.
    Losi G, Lanza M, Makovec F, Artusi R, Caselli G, Puia G.
    Neuropharmacology; 2006 Mar 01; 50(3):277-85. PubMed ID: 16236334
    [Abstract] [Full Text] [Related]

  • 39. Structural basis of NR2B-selective antagonist recognition by N-methyl-D-aspartate receptors.
    Mony L, Krzaczkowski L, Leonetti M, Le Goff A, Alarcon K, Neyton J, Bertrand HO, Acher F, Paoletti P.
    Mol Pharmacol; 2009 Jan 01; 75(1):60-74. PubMed ID: 18923063
    [Abstract] [Full Text] [Related]

  • 40. Benzyl-polyamines: novel, potent N-methyl-D-aspartate receptor antagonists.
    Igarashi K, Shirahata A, Pahk AJ, Kashiwagi K, Williams K.
    J Pharmacol Exp Ther; 1997 Nov 01; 283(2):533-40. PubMed ID: 9353367
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 41.